Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Pfizer Inc. (NYSE:PFE)

Paying users zone. Data is hidden behind: .


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Cash Flow Statement

Beginner level

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company’s balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Pfizer Inc., consolidated cash flow statement

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Net income before allocation to noncontrolling interests
Depreciation and amortization
Asset write-offs and impairments
Foreign currency loss related to Venezuela
Loss on disposal of discontinued operations
TCJA impact
Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed
Deferred taxes from continuing operations
Deferred taxes from discontinued operations
Share-based compensation expense
Benefit plan contributions in excess of expense
Other adjustments, net
Trade accounts receivable
Inventories
Other assets
Trade accounts payable
Other liabilities
Other tax accounts, net
Changes in assets and liabilities, net of acquisitions and divestitures
Adjustments to reconcile net income before allocation to noncontrolling interests to net cash provided by operating activities
Net cash provided by operating activities
Purchases of property, plant and equipment
Purchases of short-term investments
Proceeds from redemptions/sales of short-term investments
Net (purchases of) proceeds from redemptions/sales of short-term investments with original maturities of three months or less
Purchases of long-term investments
Proceeds from redemptions/sales of long-term investments
Acquisitions of businesses, net of cash acquired
Acquisitions of intangible assets
Other investing activities, net
Net cash (used in) provided by investing activities
Proceeds from short-term borrowings
Principal payments on short-term borrowings
Net proceeds from (payments on) short-term borrowings with original maturities of three months or less
Proceeds from issuances of long-term debt
Principal payments on long-term debt
Purchases of common stock
Cash dividends paid
Proceeds from exercise of stock options
Other financing activities, net
Net cash used in financing activities
Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents
Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period
Cash and cash equivalents and restricted cash and cash equivalents, at end of period

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Pfizer Inc.’s net cash provided by operating activities decreased from 2017 to 2018 and from 2018 to 2019.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Pfizer Inc.’s net cash (used in) provided by investing activities increased from 2017 to 2018 but then slightly decreased from 2018 to 2019 not reaching 2017 level.
Net cash used in financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Pfizer Inc.’s net cash used in financing activities decreased from 2017 to 2018 but then increased from 2018 to 2019 exceeding 2017 level.